Kapiket Eye Drop

KETOROLAC

Introduction to Kapiket Eye Drop

Kapiket Eye Drop is a medication designed to provide relief from eye discomfort. It is commonly used to treat inflammation and pain in the eyes, often after surgery or injury. This eye drop is a part of a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs), which help reduce inflammation and pain.

Composition of Kapiket Eye Drop

The active ingredient in Kapiket Eye Drop is Ketorolac, which works by blocking certain natural substances in your body to reduce pain and swelling.

Uses of Kapiket Eye Drop

• Relieves eye pain and discomfort
• Reduces inflammation in the eyes
• Helps in post-surgical eye care
• Alleviates symptoms of seasonal allergies affecting the eyes

Side effects of Kapiket Eye Drop

Common side effects:

• Temporary stinging or burning sensation in the eyes
• Blurred vision
• Watery eyes

Serious side effects:

• Severe eye pain
• Vision changes
• Signs of an allergic reaction, such as rash, itching, or swelling

Precautions of Kapiket Eye Drop

Before using Kapiket Eye Drop, inform your doctor if you have any allergies, especially to NSAIDs. Avoid using this medication if you have a history of bleeding disorders or are taking blood thinners. Pregnant or breastfeeding women should consult their healthcare provider before use.

How to Take Kapiket Eye Drop

• Wash your hands thoroughly before applying the eye drop.
• Tilt your head back and pull down the lower eyelid to create a small pocket.
• Hold the dropper above the eye and squeeze out a drop.
• Close your eyes for a minute or two to allow the medication to be absorbed.
• Do not touch the dropper tip or let it touch your eye to avoid contamination.

Conclusion of Kapiket Eye Drop

Kapiket Eye Drop is an effective solution for managing eye pain and inflammation. By following the prescribed instructions and taking necessary precautions, you can safely use this medication to improve your eye health. Always consult your healthcare provider for personalized advice and guidance.